The 12th Congress of The Society of Endometriosis and Uterine Disorders (SEUD 2026) Held Grandly in Frankfurt
The 12th Congress of The Society of Endometriosis and Uterine Disorders (SEUD 2026) was grandly held in Frankfurt Germany. As one of the highest-level academic events in the field of endometriosis and uterine disorders in the world, this congress brought together top global experts and scholars to discuss the latest advancements and future directions in the diagnosis and treatment of endometriosis and uterine disorders. An academic delegation from our hospital, consisting of Professor Zhang Xinmei, Chief Physician Xu Ping, Associate Chief Physician Zhu Libo, and Ph.D. candidate Liu Yuanmeng was invited to attend. They each delivered oral presentations showcasing cutting-edge research findings on innovative surgical techniques for endometriosis and adenomyosis, fertility preservation, and molecular subtyping of adenomyosis. Their reports sparked enthusiastic discussion and received high recognition from participating experts, creating a vibrant academic atmosphere. This fully demonstrates our hospital's strong capabilities and international influence in both basic and clinical research on endometriosis and adenomyosis.

Professor Xinmei Zhang presented a study titled " Factors Affecting Pregnancy Outcomes After Double-Flap Adenomyomectomy for Diffuse Adenomyosis: A Single-Center 10-Year Study." This study shared the key operative points that surgeons must focus on during the double-flap adenomyoectomy procedure, and systematically outlined several critical protective factors affecting postoperative pregnancy outcomes, including age threshold, ovarian reserve status, residual myometrial thickness exceeding 8 mm, and the golden conception window of 12 to 24 months after surgery. It sparked intense discussions among participating experts regarding the intraoperative and postoperative management of this surgical technique.

Chief Physician Ping Xu presented a report titled " Case Report and Literature Review of Obstructive Reproductive Tract Malformation and Complex Endometriosis." This study demonstrated our hospital's current experience in the diagnosis and treatment of obstructive reproductive tract malformations complicated by complex endometriosis through a key case presentation.

Associate Chief Physician Libo Zhu showed a report titled “Application of Predicled Myocutaneous Flap Combined with Vacuum Sealing Drainage in Massive Abdominal Wall Endometriosis”, This report presented our hospital's innovative use of the pedicled myocutaneous flap combined with vacuum sealing drainage in the treatment of massive abdominal wall endometriosis, fully demonstrating the unique advantages and clinical value of this exquisite surgical technique.

Ph.D. candidate Yuanmeng Liu shared the team's breakthrough findings in multi-omics molecular subtyping of adenomyosis, presenting a report titled " Integrative multi-omics characterization identifies molecular subtypes of adenomyosis associated with clinical phenotype and hormonal treatment response." This study first defines the molecular and immunological heterogeneity of adenomyosis and identifies clinically relevant subtypes associated with disease phenotype and hormonal treatment response, providing a robust molecular framework for understanding adenomyosis pathogenesis and support precision stratification and individualized therapeutic strategies.
The simultaneous presence of our hospital's four delegates on the prestigious international academic stage of SEUD 2026, and delivered conference presentations, fully demonstrating the high recognition of our hospital's research and clinical excellence by the international endometriosis and adenomyosis academic community. Engaging in profound discussions with global experts, our hospital not only showcased our academic excellence but also gained invaluable insights beyond traditional research boundaries. This milestone is poised to drive comprehensive innovation in our general gynecology department, ultimately benefiting patients worldwide.






